- New target: $303
- Previous target: $298
- Firm: Piper Sandler
- Piper Sandler lifts AbbVie price target to $303 from $298.
Piper Sandler increased its price target on AbbVie to $303 from $298. The new target implies a slight upside from the prior level. No additional details were provided.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.